Green R J, Davies M C, Roberts C J, Tendler S J
Department of Pharmaceutical Sciences, The University of Nottingham, United Kingdom.
J Biomed Mater Res. 1998 Nov;42(2):165-71. doi: 10.1002/(sici)1097-4636(199811)42:2<165::aid-jbm1>3.0.co;2-n.
Pluronic surfactants, PEO-PPO-PEO triblock copolymers, have been investigated widely due to their protein-resistant properties in applications as coatings for implants and in controlled drug release systems. We have studied a wide range of these copolymers, varying in both PEO and PPO block size, by adsorbing them to a polystyrene surface and investigating their subsequent resistance to human serum albumin adsorption. This investigation has been carried out in real time, using surface plasmon resonance, with the surfaces subsequently visualized by atomic force microscopy. This approach has allowed determination of the effect of the lengths of the PEO and PPO polymer chains on protein resistivity. For low-molecular-weight Pluronics a significant, yet not complete, reduction in albumin adsorption has been observed whereas higher molecular weight Pluronics appear to completely inhibit adsorption within the time frame of this experiment. An increase in the PPO block size of the copolymer also appears to increase its protein resistance. This work further confirms that the binding strength of the anchoring block to the hydrophobic surface, rather than the length of the protruding hydrophilic PEO chains, determines a copolymer's protein resistance capability.
普朗尼克表面活性剂,即聚环氧乙烷-聚环氧丙烷-聚环氧乙烷三嵌段共聚物,因其在植入物涂层和控释药物系统应用中具有抗蛋白质特性而受到广泛研究。我们研究了多种此类共聚物,其聚环氧乙烷和聚环氧丙烷嵌段大小各不相同,通过将它们吸附到聚苯乙烯表面并研究其随后对人血清白蛋白吸附的抗性。这项研究利用表面等离子体共振实时进行,随后通过原子力显微镜对表面进行可视化。这种方法能够确定聚环氧乙烷和聚环氧丙烷聚合物链长度对蛋白质抗性的影响。对于低分子量的普朗尼克,已观察到白蛋白吸附有显著但不完全的降低,而高分子量的普朗尼克在本实验时间范围内似乎能完全抑制吸附。共聚物中聚环氧丙烷嵌段大小的增加似乎也会增强其蛋白质抗性。这项工作进一步证实,锚定嵌段与疏水表面的结合强度,而非突出的亲水性聚环氧乙烷链的长度,决定了共聚物的蛋白质抗性能力。